These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 504071)

  • 1. [Clinical assay of a debrisoquine-diuretic compound when treating moderate arterial hypertension (author's transl)].
    Mérier GR; Baczko A
    Schweiz Rundsch Med Prax; 1979 Aug; 68(35):1123-8. PubMed ID: 504071
    [No Abstract]   [Full Text] [Related]  

  • 2. An evaluation of debrisoquine and mefruside in the treatment of hypertension in African and Indian patients.
    Seedat YK
    Curr Med Res Opin; 1980; 7(1):68-72. PubMed ID: 7428417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive action of debrisoquine (author's transl)].
    Perret L
    Schweiz Rundsch Med Prax; 1975 May; 64(21):653-9. PubMed ID: 1096131
    [No Abstract]   [Full Text] [Related]  

  • 4. The management of hypertension with special reference to debrisoquine and beta blockade.
    Turner R; White P; Benton F
    Practitioner; 1976 Apr; 216(1294):431. PubMed ID: 5718
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of arterial hypertension with a new drug combining guanabenz-mefruside].
    Frisina N; Macrì I; Ussi F
    Minerva Cardioangiol; 1984 May; 32(5):325-32. PubMed ID: 6382057
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experimentation with tensid (apropos of 60 cases)].
    Jaillard J
    Lille Med; 1976 Dec; 21 Suppl 4():904-7. PubMed ID: 14284
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of idiopathic hypertension with guanabenz-mefruside].
    Tomasi AM; Pirani R; Masoni C
    Minerva Cardioangiol; 1984 May; 32(5):339-44. PubMed ID: 6382059
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new guanabenz-mefruside drug in the treatment of arterial hypertension].
    Buemi M; Macrì I; Ussi F; Frisina N
    Minerva Cardioangiol; 1985; 33(1-2):73-80. PubMed ID: 4010975
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of a drug combination for antihypertensive therapy in general practice].
    Voigt U
    Med Welt; 1981 Sep; 32(37):1368-74. PubMed ID: 7029196
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mild and medium severe hypertension. Treatment of mild and medium severe hypertension with bendigon mite].
    Schnicke M; Olschowka U; Rezori R
    ZFA (Stuttgart); 1979 Mar; 55(7):462-5. PubMed ID: 371178
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of debrisoquine and methyldopa in hypertension.
    Pörsti P
    Ann Clin Res; 1976 Feb; 8(1):55-62. PubMed ID: 779588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and statistical considerations on a new drug in the therapy of arterial hypertension. Controlled study].
    Antognetti R; Giovine GG
    Minerva Cardioangiol; 1984 May; 32(5):313-23. PubMed ID: 6382056
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertension treatment in a health resort].
    Brommer W; Ciric D
    Med Welt; 1981 Apr; 32(14):473-5. PubMed ID: 7219161
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of beta-receptor antagonists and diuretics and their combination on blood pressure and pressure-rate product during ergometric work in hypertensive patients (author's transl)].
    Franz IW
    Z Kardiol; 1982 Jan; 71(2):129-37. PubMed ID: 7072313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hypertension with the preparation Tendor].
    Stanchev A; Shishmanova Iu; Sheĭtanov I; Georgiev I
    Vutr Boles; 1977; 16(6):34-8. PubMed ID: 341531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of hypotensive action of a diuretic, mefruside, based on the pressure-natriuresis relationship].
    Saito F; Kimura G; Shimozaki Y; Fujii T; Ishii T; Yoshida K; Abe H; Kawamura M; Deguchi F; Kawano Y
    Nihon Jinzo Gakkai Shi; 1987 Apr; 29(4):461-7. PubMed ID: 3656703
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic results with the hypotensive agent Declinax (debrisoquin) in mild and medium forms of hypertension].
    Bückert A; Schweda E; Vich V
    Schweiz Rundsch Med Prax; 1973 Nov; 62(47):1453-60. PubMed ID: 4202234
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood pressure and serum potassium during 6 months of mefruside treatment].
    Jagenburg R; Landahl S; Steen B
    Lakartidningen; 1977 Jul; 74(27-28):2509-11. PubMed ID: 875560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.